Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease

Clinical trial NCT06160622 · COMPLETED

Trial details

NCT number: NCT06160622
Sponsor: Guangdong Raynovent Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Kidney Impairment

Start date: 2023-09-26
Primary completion: 2023-12-12
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.